Author： Odou P.
Publisher： Adis International
ISSN： 1173-2563
Source： Clinical Drug Investigation, Vol.19, Iss.4, 2000-04, pp. : 283-292
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Economic modelling: `voodoo science' or useful tool?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 274, 2000-01 ,pp. :
Access to resources
Recommend
Risperidone drug monitoring beneficial?
Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. :
Should We Abandon QALYs as a Resource Allocation Tool?
PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. :
Pharmacogenetics: useful tool for tailoring chemotherapy?
Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. :
Therapeutic Drug Monitoring of Atypical Antipsychotics: Is It of Potential Clinical Value?
By Perry P.J.
CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. :